Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59

Author(s):

Linda Earnest, Daniel Fernandez Ruiz, Melissa A. Edeling, Julio Carrera Montoya, Ashley Huey Yiing Yap, Chinn Yi Wong, Lauren E. Holz, Stephanie Gras, Simon Collett, James P. Cooney, Kathryn C. Davidson, Samantha L. Grimley, Damian F.J. Purcell, Jason Roberts, Jamie Mumford, Chee Wah Tan, Lin Fa Wang, Dale I. Godfrey, Matthew Frieman, Dhiraj Hans, Elizabeth Vincan, Danielle E. Anderson, Kanta Subbarao, Marc Pellegrini, Jason M. Mackenzie, Steven Rockman, William R. Heath, Joseph Torresi

Details:

npj Vaccines, Volume 11, Issue 1, 2026-12-01, Article number 34

Article Link: Click here

Affiliations:

• University of Melbourne
• The University of Sydney
• Monash University
• UNSW Sydney
• University of Maryland School of Medicine
• RMIT University
• La Trobe University
• NUS Yong Loo Lin School of Medicine
• Royal Melbourne Hospital
• Duke-NUS Medical School
• Walter and Eliza Hall Institute of Medical Research
• Department of Microbiology & Immunology
• The Peter Doherty Institute for Infection and Immunity
• Faculty of Medicine, Dentistry and Health Sciences
• Curtin Medical School
• CSL Limited